Converting carcinomas in benign oncocytomas has been suggested as a potential anti-cancer strategy. One of the oncocytoma hallmarks is the lack of respiratory complex I (CI). Here we use genetic ablation of this enzyme to induce indolence in two cancer types, and show this is reversed by allowing the stabilization of Hypoxia Inducible Factor-1 alpha (HIF-1α). We further show that on the long run CI-deficient tumors re-adapt to their inability to respond to hypoxia, concordantly with the persistence of human oncocytomas. We demonstrate that CI-deficient tumors survive and carry out angiogenesis, despite their inability to stabilize HIF-1α. Such adaptive response is mediated by tumor associated macrophages, whose blockage improves the effect of CI ablation. Additionally, the simultaneous pharmacological inhibition of CI function through metformin and macrophage infiltration through PLX-3397 impairs tumor growth in vivo in a synergistic manner, setting the basis for an efficient combinatorial adjuvant therapy in clinical trials.

Inducing cancer indolence by targeting mitochondrial Complex I is potentiated by blocking macrophage-mediated adaptive responses / Kurelac, I.; Iommarini, L.; Vatrinet, R.; Amato, L. B.; De Luise, M.; Leone, G.; Girolimetti, G.; Umesh Ganesh, N.; Bridgeman, V. L.; Ombrato, L.; Columbaro, M.; Ragazzi, M.; Gibellini, L.; Sollazzo, M.; Feichtinger, R. G.; Vidali, S.; Baldassarre, M.; Foriel, S.; Vidone, M.; Cossarizza, A.; Grifoni, D.; Kofler, B.; Malanchi, I.; Porcelli, A. M.; Gasparre, G.. - In: NATURE COMMUNICATIONS. - ISSN 2041-1723. - 10:1(2019), pp. 903-N/A. [10.1038/s41467-019-08839-1]

Inducing cancer indolence by targeting mitochondrial Complex I is potentiated by blocking macrophage-mediated adaptive responses

Kurelac I.;Leone G.;Ragazzi M.;Gibellini L.
Membro del Collaboration Group
;
Baldassarre M.;Cossarizza A.;
2019

Abstract

Converting carcinomas in benign oncocytomas has been suggested as a potential anti-cancer strategy. One of the oncocytoma hallmarks is the lack of respiratory complex I (CI). Here we use genetic ablation of this enzyme to induce indolence in two cancer types, and show this is reversed by allowing the stabilization of Hypoxia Inducible Factor-1 alpha (HIF-1α). We further show that on the long run CI-deficient tumors re-adapt to their inability to respond to hypoxia, concordantly with the persistence of human oncocytomas. We demonstrate that CI-deficient tumors survive and carry out angiogenesis, despite their inability to stabilize HIF-1α. Such adaptive response is mediated by tumor associated macrophages, whose blockage improves the effect of CI ablation. Additionally, the simultaneous pharmacological inhibition of CI function through metformin and macrophage infiltration through PLX-3397 impairs tumor growth in vivo in a synergistic manner, setting the basis for an efficient combinatorial adjuvant therapy in clinical trials.
2019
10
1
903
N/A
Inducing cancer indolence by targeting mitochondrial Complex I is potentiated by blocking macrophage-mediated adaptive responses / Kurelac, I.; Iommarini, L.; Vatrinet, R.; Amato, L. B.; De Luise, M.; Leone, G.; Girolimetti, G.; Umesh Ganesh, N.; Bridgeman, V. L.; Ombrato, L.; Columbaro, M.; Ragazzi, M.; Gibellini, L.; Sollazzo, M.; Feichtinger, R. G.; Vidali, S.; Baldassarre, M.; Foriel, S.; Vidone, M.; Cossarizza, A.; Grifoni, D.; Kofler, B.; Malanchi, I.; Porcelli, A. M.; Gasparre, G.. - In: NATURE COMMUNICATIONS. - ISSN 2041-1723. - 10:1(2019), pp. 903-N/A. [10.1038/s41467-019-08839-1]
Kurelac, I.; Iommarini, L.; Vatrinet, R.; Amato, L. B.; De Luise, M.; Leone, G.; Girolimetti, G.; Umesh Ganesh, N.; Bridgeman, V. L.; Ombrato, L.; Col...espandi
File in questo prodotto:
File Dimensione Formato  
s41467-019-08839-1.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 8.68 MB
Formato Adobe PDF
8.68 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1203182
Citazioni
  • ???jsp.display-item.citation.pmc??? 34
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 48
social impact